| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/13/2004 | EP0776968B1 Liquid medium for nerve cells, process for producing the same and method for incubating nerve cells with the use of the same |
| 10/13/2004 | EP0688361B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | CN2647864Y Reactor for in vitro blood vessel culture |
| 10/13/2004 | CN1537167A Von willebrand factor (VWF)-cleaving enzyme |
| 10/13/2004 | CN1537166A New elongase gene and production of Delta 9-polyunsaturated fatty acids |
| 10/13/2004 | CN1537163A Subtilase variants |
| 10/13/2004 | CN1537161A Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 10/13/2004 | CN1537160A Leguminous bacterium having potentiated mitrogen fixation ability |
| 10/13/2004 | CN1537117A 干扰素γ多肽变体 IFN-γ polypeptide variant |
| 10/13/2004 | CN1537032A Plate and method for high throughput screening |
| 10/13/2004 | CN1536089A Promotor for expressing gene in fungal cell |
| 10/13/2004 | CN1536076A Method for making adult bone marrow mesenchymal stem cells implement in vito amplification and directionally inducing them to be differentiated into myocardium-like cells |
| 10/13/2004 | CN1536075A Method for inducing bone marrow mesenchymal stem cells to differentiate into insulin-like cells |
| 10/13/2004 | CN1536074A Method for genetically modifying and inducing intracerebral transplantation mesenchymal stem cells to be differentitated into neuron |
| 10/13/2004 | CN1536073A Method for producing dopaminergic nerve cell by utilizing nerve stem cell internal amplification and directional induction differentiation |
| 10/13/2004 | CN1535975A Method for synthesizing secoiridoid glycosides compound |
| 10/13/2004 | CN1170941C Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 10/13/2004 | CN1170940C Plant with modified growth and method for obtained said plant |
| 10/13/2004 | CN1170935C Astaxanthin synthetic enzyme |
| 10/13/2004 | CN1170931C Vasculogenesis correlation molecule |
| 10/13/2004 | CN1170926C Use of stem cell factor and soluble interleukin-6 receptor for ex vivo expansion of hematopoietic multipotential cells |
| 10/13/2004 | CN1170594C 弯曲菌疫苗 Campylobacter vaccine |
| 10/12/2004 | US6804611 Apparatus and method for automated protein design |
| 10/12/2004 | US6803499 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| 10/12/2004 | US6803498 Maize cellulose synthases and uses thereof |
| 10/12/2004 | US6803497 By identifying a diagnostic fragment; for agrifood industries; used to create hybrid plants |
| 10/12/2004 | US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis |
| 10/12/2004 | US6803450 Fusion protein; genetic engineering; energy storage |
| 10/12/2004 | US6803449 Polypeptide for use in the diagnosis and treatment viral diseases |
| 10/12/2004 | US6803234 Expression vector for use in the transduction of human chondrocyte; obtain chondrocytes, incubate with expression vector, monitor cell for expression of reporter molecule |
| 10/12/2004 | US6803233 Evaluating modulators of brain disorders; obtain brain cells, expose brain cells to modulators, monitor cells for adjustment in brain inflammatory reaction |
| 10/12/2004 | US6803232 Neuropeptide y (npy) receptor (designated npy- y7) used to express the receptor in cells which can then be used for drug screening |
| 10/12/2004 | US6803225 Expression vector for use transformation of yeast cells |
| 10/12/2004 | US6803213 Having one or more amino acid substitutions that confer receptor agonist or antagonist properties |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803209 Nutrient for use in the propagation of microorganism and the generation of heterologous proteins |
| 10/12/2004 | US6803206 Method for identifying endocrine disruptors and kit for carrying out the same |
| 10/12/2004 | US6803200 Compositions and methods for the release of nucleic acid molecules from solid matrices |
| 10/12/2004 | US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 10/12/2004 | US6803043 Basbo27 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 10/12/2004 | US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM |
| 10/12/2004 | US6803037 Higher proliferation rate |
| 10/12/2004 | US6803036 Treating peripheral blood mononuclear cells from donor with transforming growth factor beta, interleukin-2 and at least one other t cell activator; allogenic bone marrow transplants |
| 10/12/2004 | CA1341458C Modified human t-pa |
| 10/07/2004 | WO2004085632A1 Control of stem cell differentiation induction and differentiation potency |
| 10/07/2004 | WO2004085631A2 Canine embryonic stem cells |
| 10/07/2004 | WO2004085630A1 Perivascular mesenchymal precursor cells |
| 10/07/2004 | WO2004085620A2 Novel attached cell lines |
| 10/07/2004 | WO2004085616A2 Regulation of self-renewal in stem cells |
| 10/07/2004 | WO2004085606A1 Cell culture medium and solidified preparation of cell adhesion protein or peptide |
| 10/07/2004 | WO2004085508A1 Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
| 10/07/2004 | WO2004085473A2 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 10/07/2004 | WO2004084967A1 Blood vessel-specific organogenesis from embryonic stem cells on three-dimensional matrigel layer |
| 10/07/2004 | WO2004084950A2 Cell targeting methods and compositions |
| 10/07/2004 | WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 10/07/2004 | WO2004084921A1 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 10/07/2004 | WO2004084838A2 Identification, quantification, and characterization of t cells and t cell antigens |
| 10/07/2004 | WO2004084828A2 Keratinocyte-fibrocyte concomitant grafting for wound healing |
| 10/07/2004 | WO2004084823A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 10/07/2004 | WO2004084816A2 IMPROVED CD4-IgG2 FORMULATIONS |
| 10/07/2004 | WO2004084807A2 Micro-cluster compositions |
| 10/07/2004 | WO2004084711A2 Methods of detecting neurological disorders |
| 10/07/2004 | WO2004072220A3 Process of sex selection of mammal spermatozoa and method to control quality of frozen sexed semen doses |
| 10/07/2004 | WO2004067750A3 Xenorhabdus tc proteins and genes for pest control |
| 10/07/2004 | WO2004048402B1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 10/07/2004 | WO2004045517A3 Method for the diagnosis and treatment of vascular disease |
| 10/07/2004 | WO2004042035A3 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders |
| 10/07/2004 | WO2004033396A3 Method for enriching adherent monocyte populations |
| 10/07/2004 | WO2004018636A3 Methods for modulating transcriptional activation using mint proteins |
| 10/07/2004 | WO2004007674A3 Neuronal and retinal gene expression patterns |
| 10/07/2004 | WO2003105770A3 Carbocyclic nucleoside analogs as rna-antivirals |
| 10/07/2004 | WO2003101386A3 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 10/07/2004 | WO2003089575A3 Antibodies that specifically bind to tl5 |
| 10/07/2004 | WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | WO2002100250A8 Wit 3.0, a novel gene to control soft tissue wound healing |
| 10/07/2004 | WO2002092000A3 Hbm variants that modulate bone mass and lipid levels |
| 10/07/2004 | WO2002088317A3 Fusion molecules and methods for treatment of immune diseases |
| 10/07/2004 | US20040199945 Preparing heavy chain binding protein microarray in plant cells via genetic transformation and gene expression; tissue engineering; diagnostic antibody microarrays |
| 10/07/2004 | US20040199944 Comprises fusion protein coding optimized transit peptide for use in the generation of herbicide resistant plants; tissue engineering |
| 10/07/2004 | US20040199943 Transgenic green coffee bean comprising galatomannans with enhanced branching; enhancing solubility and storability of coffee particles; tissue engineering |
| 10/07/2004 | US20040199939 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 10/07/2004 | US20040199935 Cytoplasmic transfer to de-differentiate recipient cells |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040198681 Administering to human or animal at least one polypeptide or a nucleic acid sequence encoding said polypeptide; protein design or protein engineering in the production of polypeptides allowing delivery of food essential amino acids for milk production in cows, farm animal production or human food |
| 10/07/2004 | US20040198678 Intravascular delivery of non-viral nucleic acid |
| 10/07/2004 | US20040198661 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 10/07/2004 | US20040198659 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 10/07/2004 | US20040198651 Secreted proteins |
| 10/07/2004 | US20040197915 Transgenic tobacco expressing phosphoenol pyruvate carboxylase of poaceae; enhanced light processing capabilites |
| 10/07/2004 | US20040197908 Using cartilage differentiation inducing broth, undifferentiated mesenchymal cells and ultrasonic pulsation to induce, differentiate and propagate bone tissue; treating bone disorders |
| 10/07/2004 | US20040197907 Apparatus comprising polyethylene glycol and polylactide hydrophilic segments for propagating parenchymal cells; bioreactors |
| 10/07/2004 | US20040197905 Methods and devices for monitoring cellular metabolism in microfluidic cell-retaining chambers |
| 10/07/2004 | US20040197904 Method for separating cells using immunorosettes |
| 10/07/2004 | US20040197903 Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15 |
| 10/07/2004 | US20040197902 Transgenic mammalian endothelial progenitor cells for use in the treatment of vision defects; gene therapy and neovascularization |
| 10/07/2004 | US20040197901 Ancillary composition for the preparation of committed mature dentritic cells |
| 10/07/2004 | US20040197900 Generating dopaminergic neurons by contacting neuroprogenitor cells with transcription elongation factor, foggy, for treatment of drug addiction, nervous system, behavioral and sexual disorders |